As CDMOs attend the J.P. Morgan Healthcare Conference in San Francisco, Jan. 13-16, analysts remain cautiously optimistic about the industry’s outlook in 2025.
The award to ReciBioPharm, a division of Recipharm, will support the global deployment of RNA continuous manufacturing technologies to low- and middle-income countries.
